DANA JONES: Open Payments
NPI 1932681574 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 40 payments from 9 companies in 2025. Trend: 2023 $289 · 2024 $373 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $303 |
| ViiV Healthcare Company | 18 | $259 |
| ABBVIE INC. | 6 | $97 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| EMD Serono, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: DOVATO, Biktarvy, CABENUVA, TRELEGY ELLIPTA, CREON, XIFAXAN, UBRELVY, QULIPTA.
Industry payments across AR — which companies pay providers there.
